Company Profile
ACADIA Pharmaceuticals Inc. Stock Price, News & Analysis
- Ticker:
- ACAD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, ACADIA Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
22.60 USD (+2.31%)
Close
Last updated: June 23, 2026 at 00:00
3.87B USD
Market cap
Why the stock is moving
ACAD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
ACADIA Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ACADIA Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
ACADIA Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, ACADIA Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ACADIA Pharmaceuticals Inc. (ACAD)?
ACADIA Pharmaceuticals Inc. (ACAD) most recently closed at 22.60 USD, a +2.31% move versus the previous session.
What is the market cap of ACADIA Pharmaceuticals Inc. (ACAD)?
ACADIA Pharmaceuticals Inc. currently has a market capitalization of 3.87B USD on BioPharmSignal.
What does ACADIA Pharmaceuticals Inc. do?
ACADIA Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ACAD stock listed?
ACADIA Pharmaceuticals Inc. (ACAD) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, ACADIA Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Pharmaceuticals?
ACADIA Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is ACADIA Pharmaceuticals Inc. targeting with Pharmaceuticals?
ACADIA Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.